Prasson Pankaj, Bai Xueli, Zhang Qi, Liang Tingbo
Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, Zhejiang, China.
Surg Endosc. 2016 Aug;30(8):3582-90. doi: 10.1007/s00464-015-4657-0. Epub 2015 Dec 30.
Laparoscopic common bile duct exploration and endoscopic retrograde cholangiopancreatography (ERCP) are secure and effective techniques that recently been used to treat bile duct stones. The purpose of this research was to assess the intra-procedural efficacy and postprocedural upshots of the laparoscopic common bile duct exploration plus laparoscopic cholecystectomy (LCBDE) and ERCP plus laparoscopic cholecystectomy (ERCP + LC).
All studies contrasting one-stage (LCBDE) with two-stage (ERCP/EST + LC) managements in patients with concomitant gallstones and common bile duct (CBD) stones were included. The primary outcomes were CBD stone clearance, postoperative morbidity, and mortality, while secondary outcomes were conversion with other techniques, duration of stay in hospital, number of procedures used per patient, and operating time. Data were pooled by meta-analysis.
Fourteen studies with 1600 participants were identified. Each arm contains 800 participants. There is no significant difference between the two arms regarding successful CBD stone clearance (RR = 0.96, P = 0.15), mortality (RR = 1.74, P = 0.33), morbidity (RR = 0.89, P = 0.32), conversion to additional procedure (RR = 1.44, P = 0.09), operating time (MD = -1.43 min, P = 0.95), hospital stay (MD = 1.31 days, P = 0.17), and retained stone rate (RR = 1.73, P = 0.38).
One- and two-stage management had similar efficacy and safety in terms of CBD stone clearance rate, mortality, morbidity, operating time, hospital stay, and retained stone rate. One-stage management may reduce additional procedure.
腹腔镜胆总管探查术和内镜逆行胰胆管造影术(ERCP)是近年来用于治疗胆管结石的安全有效的技术。本研究的目的是评估腹腔镜胆总管探查术联合腹腔镜胆囊切除术(LCBDE)和ERCP联合腹腔镜胆囊切除术(ERCP + LC)的术中疗效和术后结果。
纳入所有对比同期胆囊结石合并胆总管结石患者一期(LCBDE)与二期(ERCP/EST + LC)治疗的研究。主要结局为胆总管结石清除率、术后发病率和死亡率,次要结局为转为其他技术、住院时间、每位患者的手术次数和手术时间。通过荟萃分析汇总数据。
确定了14项研究,共1600名参与者。每组各有800名参与者。两组在胆总管结石清除成功率(RR = 0.96,P = 0.15)、死亡率(RR = 1.74,P = 0.33)、发病率(RR = 0.89,P = 0.32)、转为其他手术(RR = 1.44,P = 0.09)、手术时间(MD = -1.43分钟,P = 0.95)、住院时间(MD = 1.31天,P = 0.17)和残留结石率(RR = 1.73,P = 0.38)方面无显著差异。
一期和二期治疗在胆总管结石清除率、死亡率、发病率、手术时间、住院时间和残留结石率方面具有相似的疗效和安全性。一期治疗可能减少额外的手术。